Hepatosplenic T cell lymphoma pathophysiology: Difference between revisions
No edit summary |
Mahshid |
||
(19 intermediate revisions by 2 users not shown) | |||
Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
Hepatosplenic T cell lymphoma arises from an immature cytotoxic [[T-cell]] clonally expressing the γδ [[T-cell receptor]]. Gamma delta (γδ) T cells constitute 1% to 5% of the circulating lymphocytes in human blood. These cells preferentially home in on some epithelial rich tissues and sinusoidal areas of the splenic red pulp where they represent up to 30% of the whole T-cell population. Hepatosplenic γδ T-cell lymphoma (HSTCL) is a rare aggressive subtype of extra nodal lymphoma. Genes involved in the pathogenesis of hepatosplenic T cell lymphoma include isochromosome 7q, TRG@, and T-cell receptor (TCR) Gamma/Delta genes. On gross pathology, diffuse enlargment of [[liver]] and [[spleen]] are characteristic findings of hepatosplenic T cell lymphoma. On microscopic histopathological analysis, monotonous appearance with a small amount of [[cytoplasm]] and inconspicuous [[nucleoli]] are characteristic findings of neoplastic cells of hepatosplenic T cell lymphoma. | |||
==Genetics== | ==Genetics== | ||
* Genes involved in the pathogenesis of hepatosplenic T cell lymphoma | * Genes involved in the pathogenesis of hepatosplenic T cell lymphoma are listed below.<ref name=cancer.gov> Hepatosplenic T cell lymphoma. Surveillance, Epidemiology, and End Results Program. http://seer.cancer.gov/seertools/hemelymph/51f6cf56e3e27c3994bd52ee/. Accessed on February 22, 2016</ref> | ||
:* 2-5 copies of i(7)(q10) | :* 2-5 copies of i(7)(q10) | ||
:* Isochromosome 7q present | :* Isochromosome 7q present | ||
Line 13: | Line 14: | ||
:* T-cell receptor (TCR) Gamma/Delta genes are clonally rearranged | :* T-cell receptor (TCR) Gamma/Delta genes are clonally rearranged | ||
:* Trisomy 8 | :* Trisomy 8 | ||
===Immunophenotype<ref name=cancer.gov> Hepatosplenic T cell lymphoma. Surveillance, Epidemiology, and End Results Program. http://seer.cancer.gov/seertools/hemelymph/51f6cf56e3e27c3994bd52ee/. Accessed on February 22, 2016</ref>=== | |||
The immunophenotype for hepatosplenic T-cell lymphoma is a post-thymic, immature [[T-cell]]. | The immunophenotype for hepatosplenic T-cell lymphoma is a post-thymic, immature [[T-cell]]. | ||
Line 30: | Line 30: | ||
|} | |} | ||
==Association== | |||
* Hepatosplenic T cell lymphoma is seen more often in | |||
:* Immunosuppressed solid organ transplant recipients<ref>[http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=8085554&query_hl=10&itool=pubmed_ExternalLink]</ref><ref>Ross CW, Schnitzer B, Sheldon S, Braun DK, Hanson CA. "Gamma/delta T-cell posttransplantation lymphoproliferative disorder primarily in the spleen." '''Am J Clin Pathol'''. 1994 Sep;102(3):310-5. PMID: 8085554</ref><ref>[http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=11224598&query_hl=12&itool=pubmed_ExternalLink]</ref><ref>Macon WR, Levy NB, Kurtin PJ, Salhany KE, Elkhalifa MY, Casey TT, Craig FE, Vnencak-Jones CL, Gulley ML, Park JP, Cousar JB. "Hepatosplenic alphabeta T-cell lymphomas: a report of 14 cases and comparison with hepatosplenic gammadelta T-cell lymphomas." '''Am J Surg Pathol'''. 2001 Mar;25(3):285-96. PMID: 11224598</ref> | |||
:* Patients treated with the immunosuppressants [[azathioprine]], [[infliximab]], and [[adalimumab]] | |||
:* Patients with [[inflammatory bowel disease]] | |||
==Gross Pathology== | |||
* Spleen is enlarged with diffuse involvement of the red pulp and absence of any gross lesions | |||
* Diffuse hepatic enlargement is present | |||
== | ==Microscopic Pathology== | ||
The [[ | The characteristic features of neoplastic cells in hepatosplenic T cell lymphoma include: | ||
* Monotonous appearance | |||
* Small amount of [[cytoplasm]] | |||
* Inconspicuous [[nucleoli]] | |||
= | <gallery widths=200px> | ||
Image:Hepatosplenic T cell lymphoma peripheral blood smear|Peripheral blood smear showing large atypical lymphoid cells with indented nuclei .<ref name=jmedicalcasereports>Hepatosplenic gamma delta T-cell lymphoma. Journal of medical case reports. http://www.jmedicalcasereports.com/content/7/1/269. Accessed on February 24, 2016 </ref> | |||
Image:Hepatosplenic T cell lymphoma bone marrow biopsy.jpg|A: Bone marrow biopsy showing cellular marrow with diffuse intrasinusoidal and interstitial lymphoid cell infiltrates (Jenner Giemsa, ×100); B: Arrows indicating intrasinusoidal lymphoid cell infiltrate (Jenner Giemsa, ×400).<ref name=jmedicalcasereports>Hepatosplenic gamma delta T-cell lymphoma. Journal of medical case reports. http://www.jmedicalcasereports.com/content/7/1/269. Accessed on February 24, 2016 </ref> | |||
= | </gallery> | ||
{| style="border: 0px; font-size: 90%; margin: 3px;" align=center | |||
|+ ''' Microscopic appearance of hepatosplenic T cell lymphoma | |||
! style="background: #4479BA; color:#FFF;" | Sites of involvement | |||
! style="background: #4479BA; color:#FFF;" | Description | |||
|- | |||
| style="padding: 5px 5px; background: #DCDCDC;" | Spleen and liver | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
* Are always involved | |||
* Distinct [[sinusoidal]] pattern of infiltration which spares the splenic [[white pulp]] and hepatic [[portal triads]] | |||
|- | |||
| style="padding: 5px 5px; background: #DCDCDC;" | Bone marrow | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
* Commonly involved | |||
* Detection of the neoplastic infiltrate may be difficult due to diffuse, interstitial pattern | |||
* [[Immunohistochemistry]] can aid in the detection | |||
|- | |||
| style="padding: 5px 5px; background: #DCDCDC;" | Peripheral blood | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
* Cells of a similar morphology observed in solid organs are observed in peripheral [[blood]] | |||
|} | |||
==References== | ==References== | ||
Line 61: | Line 85: | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
[[Category:Up-To-Date]] | |||
[[Category:Oncology]] | |||
[[Category:Medicine]] | |||
[[Category:Hematology]] | |||
[[Category:Immunology]] | |||
[[Category:Gastroenterology]] | |||
[[Category:Hepatology]] |
Latest revision as of 02:02, 27 November 2017
Hepatosplenic T cell lymphoma Microchapters |
Differentiating Hepatosplenic T cell lymphoma from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Hepatosplenic T cell lymphoma pathophysiology On the Web |
American Roentgen Ray Society Images of Hepatosplenic T cell lymphoma pathophysiology |
Directions to Hospitals Treating Hepatosplenic T cell lymphoma |
Risk calculators and risk factors for Hepatosplenic T cell lymphoma pathophysiology |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [3]Associate Editor(s)-in-Chief: Sowminya Arikapudi, M.B,B.S. [4]
Overview
Hepatosplenic T cell lymphoma arises from an immature cytotoxic T-cell clonally expressing the γδ T-cell receptor. Gamma delta (γδ) T cells constitute 1% to 5% of the circulating lymphocytes in human blood. These cells preferentially home in on some epithelial rich tissues and sinusoidal areas of the splenic red pulp where they represent up to 30% of the whole T-cell population. Hepatosplenic γδ T-cell lymphoma (HSTCL) is a rare aggressive subtype of extra nodal lymphoma. Genes involved in the pathogenesis of hepatosplenic T cell lymphoma include isochromosome 7q, TRG@, and T-cell receptor (TCR) Gamma/Delta genes. On gross pathology, diffuse enlargment of liver and spleen are characteristic findings of hepatosplenic T cell lymphoma. On microscopic histopathological analysis, monotonous appearance with a small amount of cytoplasm and inconspicuous nucleoli are characteristic findings of neoplastic cells of hepatosplenic T cell lymphoma.
Genetics
- Genes involved in the pathogenesis of hepatosplenic T cell lymphoma are listed below.[1]
- 2-5 copies of i(7)(q10)
- Isochromosome 7q present
- Numerical and structural aberrations of the second chromosome 7
- Rearrangement TRG@, TRB@ genes
- T-cell receptor (TCR) Gamma/Delta genes are clonally rearranged
- Trisomy 8
Immunophenotype[1]
The immunophenotype for hepatosplenic T-cell lymphoma is a post-thymic, immature T-cell.
Status | Antigens |
Positive | CD3, TCRδ1, TIA-1, granzyme M, multiple killer immunoglobulin-like receptors (KIR) isoforms |
Negative | CD4, CD5, CD8, granzyme B, perforin, CD94 |
Association
- Hepatosplenic T cell lymphoma is seen more often in
- Immunosuppressed solid organ transplant recipients[2][3][4][5]
- Patients treated with the immunosuppressants azathioprine, infliximab, and adalimumab
- Patients with inflammatory bowel disease
Gross Pathology
- Spleen is enlarged with diffuse involvement of the red pulp and absence of any gross lesions
- Diffuse hepatic enlargement is present
Microscopic Pathology
The characteristic features of neoplastic cells in hepatosplenic T cell lymphoma include:
-
Peripheral blood smear showing large atypical lymphoid cells with indented nuclei .[6]
-
A: Bone marrow biopsy showing cellular marrow with diffuse intrasinusoidal and interstitial lymphoid cell infiltrates (Jenner Giemsa, ×100); B: Arrows indicating intrasinusoidal lymphoid cell infiltrate (Jenner Giemsa, ×400).[6]
Sites of involvement | Description |
---|---|
Spleen and liver |
|
Bone marrow |
|
Peripheral blood |
|
References
- ↑ 1.0 1.1 Hepatosplenic T cell lymphoma. Surveillance, Epidemiology, and End Results Program. http://seer.cancer.gov/seertools/hemelymph/51f6cf56e3e27c3994bd52ee/. Accessed on February 22, 2016
- ↑ [1]
- ↑ Ross CW, Schnitzer B, Sheldon S, Braun DK, Hanson CA. "Gamma/delta T-cell posttransplantation lymphoproliferative disorder primarily in the spleen." Am J Clin Pathol. 1994 Sep;102(3):310-5. PMID: 8085554
- ↑ [2]
- ↑ Macon WR, Levy NB, Kurtin PJ, Salhany KE, Elkhalifa MY, Casey TT, Craig FE, Vnencak-Jones CL, Gulley ML, Park JP, Cousar JB. "Hepatosplenic alphabeta T-cell lymphomas: a report of 14 cases and comparison with hepatosplenic gammadelta T-cell lymphomas." Am J Surg Pathol. 2001 Mar;25(3):285-96. PMID: 11224598
- ↑ 6.0 6.1 Hepatosplenic gamma delta T-cell lymphoma. Journal of medical case reports. http://www.jmedicalcasereports.com/content/7/1/269. Accessed on February 24, 2016